The Quick Dementia Rating System (QDRS): A rapid dementia stagingtool

Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring

Volumn 1, Issue 2, 2015, Pages 249-259

  Galvin, James E ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Clinical dementia rating; Clinical trials; Dementia; Neurocognitive disorders; Staging

Indexed keywords

EID: 84938696106     PISSN: None     EISSN: 23528729     Source Type: Journal    
DOI: 10.1016/j.dadm.2015.03.003     Document Type: Article

References (41)

1. Albert M.S., DeKosky S.T., Dickson D., Dubois B., Feldman H.H., Fox N.C., et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011, 7:270-279.
2. Petersen R.C., Doody R., Kurz A., Mohs R.C., Morris J.C., Rabins P.V., et al. Current concepts in mild cognitive impairment. Arch Neurol 2001, 58:1985-1992.
3. McKhann G.M., Knopman D.S., Chertkow H., Hyman B.T., Jack C.R., Kawas C.H., et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011, 7:263-269.
4. Galvin J.E., Roe C.M., Powlishta K.K., Coats M.A., Muich S.J., Grant E., et al. The AD8: a brief informant interview to detect dementia. Neurology 2005, 65:559-564.
5. Holsinger T., Deveau J., Boustani M., Williams J.W. Does this patient have dementia?. JAMA 2007, 297:2391-2404.
6. Galvin J.E. Dementia screening, biomarkers and protein misfolding: implications for public health and diagnosis. Prion 2011, 5:16-21.
7. Cacchione P.Z., Powlishta K.K., Grant E.A., Buckles V.D., Morris J.C. Accuracy of collateral source reports in very mild to mild dementia of the Alzheimer type. J Am Geriatr Soc 2003, 51:819-823.
8. Carr D.B., Gray S., Baty J., Morris J.C. The value of informant vs. individual's complaints of memory impairment in early dementia. Neurology 2000, 55:1724-1726.
9. Galvin J.E., Roe C.M., Xiong C., Morris J.C. The validity and reliability of the AD8 informant interview for dementia. Neurology 2006, 67:1942-1948.
10. McCarten J.R., Anderson P., Kuskowski M.A., McPherson S.E., Borson S. Screening for cognitive impairment in an elderly veteran population: acceptability and results using different versions of the Mini-Cog. J Am Geriatr Soc 2011, 59:309-313.
11. Morris J.C. The Clinical Dementia Rating (CDR)-current version and scoring rules. Neurology 1993, 43:2412-2414.
12. Teri L., Truax P., Logsdon R., Uomoto J., Zarit S., Vitaliano P.P. Assessment of behavioral problems in dementia: the revised memory and behavior problems checklist. Psychol Aging 1992, 7:622-631.
13. Logsdon R.G., Gibbons L.E., McCurry S.M., Teri L. Assessing quality of life in older adults with cognitive impairment. Psychosom Med 2002, 64:510-519.
14. Herbert R., Bravo G., Preville M. Reliability, validity, and reference values of the Zarit Burden Interview for assessing informal caregivers of community-dwelling older persons with dementia. Can J Aging 2000, 19:494-507.
15. Galvin J.E., Valois L., Zweig Y. Collaborative transdisciplinary team approach for dementia care. Neurodegener Dis Manag 2014, 4:455-469.
16. McKeith I.G., Dickson D.W., Lowe J., Emre M., O'Brien J.T., Feldman H., et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005, 65:1863-1872. Consortium on DLB.
17. Rascovsky K., Hodges J.R., Knopman D., Mendez M.F., Kramer J.H., Neuhaus J., et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 2011, 134:2456-2477.
18. Gorno-Tempini M.L., Hillis A.E., Weintraub S., Kertesz A., Mendez M., Cappa S.F., et al. Classification of primary progressive aphasia and its variants. Neurology 2011, 76:1006-1014.
19. Sachdev P., Kalaria R., O'Brien J., Skoog I., Alladi S., Black S.E., et al. Diagnostic criteria for vascular cognitive disorders: a VASCOG statement. Alzheimer Dis Assoc Disord 2014, 28:206-218.
20. Reisberg B. Global measures: utility in defining and measuring treatment response in dementia. Int Psychogeriatr 2007, 19:421-456.
21. Goetz C.G., Fahn S., Martinez-Martin P., Poewe W., Sampaio C., Stebbins G.T., et al. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): process, format, and clinimetric testing plan. Mov Disord 2007, 22:41-47.
22. Kaufer D.I., Cummings J.L., Ketchel P., Smith V., MacMillan A., Shelley T., et al. Validation of the NPI-Q, a brief clinical form of the neuropsychiatric inventory. J Neuropsychiatry Clin Neurosci 2000, 12:233-239.
23. Ferman T.J., Smith G.E., Boeve B.F., Ivnik R.J., Petersen R.C., Knopman D., et al. DLB fluctuations: specific features that reliably differentiate DLB from AD and normal aging. Neurology 2004, 62:181-187.
24. Johns M.W. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991, 14:540-545.
25. Pfeffer R.I., Kurosaki T.T., Harrah C.H., Chance J.M., Filos S. Measurement of functional activities in older adults in the community. J Gerontol 1982, 37:323-329.
26. Kroenke K., Spitzer R.L., Williams J.B., Löwe B. An ultra-brief screening scale for anxiety and depression: the PHQ-4. Psychosomatics 2009, 50:613-621.
27. Folstein M.F., Folstein S.E., McHugh P.R. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975, 12:189-198.
28. Brandt J., Corwin J., Krafft L. Is verbal recognition memory really different in Huntington's and Alzheimer's disease. J Clin Exp Neuropsychol 1992, 14:773-784.
29. Thurstone L.L., Thurstone L.G. Examiner manual for the SRA Primary Mental Abilities Test 1949, Science Research Associates, Chicago.
30. Goodglass H., Kaplan E. The assessment of aphasia and related disorders 1983, Lea & Febiger, Philadelphia. 2nd ed.
31. Crowe S.F. Does the letter number sequencing task measure anything more than digit span?. Assessment 2000, 7:113-117.
32. Reitan R.M. Validity of the trail making test as an indicator of organic brain damage. Percept Mot Skills 1958, 8:271-276.
33. Yamamoto S., Mogi N., Umegaki H., Suzuki Y., Ando F., Shimokata H., et al. The clock drawing test as a valid screening method for mild cognitive impairment. Dement Geriatr Cogn Disord 2004, 18:172-179.
34. Snaith R.P. The Hospital Anxiety and Depression Scale. Health Qual Life Outcomes 2003, 1:29.
35. Streiner D.L., Norman G.R. Health measurement scale: a practical guide to their development and use 2008, Oxford University Press, Oxford, England. 4th ed.
36. Monahan P.O., Boustani M., Alder C., Galvin J.E., Perkins A.J., Healey P., et al. A practical clinical tool to monitor dementia symptoms: The HABC-Monitor. Clin Interv Aging 2012, 7:143-157.
37. Fleiss J.L., Chilton N.W. The measurement of interexaminer agreement on periodontal disease. J Periodontal Res 1983, 18:601-606.
38. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40:373-383.
39. Galasko D., Bennett D., Sano M., Ernesto C., Thomas R., Grundman M., et al. An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. The Alzheimer' Disease Cooperative Study. Alzheimer Dis Assoc Disord 1997, 11(suppl 2):S33-S39.
40. Schneider L.S., Olin J.T., Doody R.S., Clark C.M., Morris J.C., Reisberg B., et al. Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord 1997, 11(Suppl 2):S22-32.
41. Nasreddine Z.S., Phillips N.A., Bédirian V., Charbonneau S., Whitehead V., Collin I., et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005, 53:695-699.